Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
03:50:06 EDT Wed 30 Apr 2025
Enter Symbol
or Name
USA
CA



Z:NBY - NOVABAY PHARMACEUTICALS INC - https://investors.novabay.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
NBY - Z0.10.4436·7.651.90.58528.314720.5852  0.61  0.58329.079  0.3611Apr 29Apr 0415 min RT 2¢

Recent Trades - Last 10 of 72
Time ETExPriceChangeVolume
19:57:16Z0.581-0.0041
15:59:23Z0.5816-0.003420
15:51:07Z0.585 192
15:49:03Z0.585 200
15:49:03Z0.585 19
15:39:06Z0.5833-0.0017200
15:28:17Z0.5821-0.00298
15:19:30Z0.585 89
15:04:50Z0.585 900
15:04:50Z0.585 400

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-04-04 20:36U:NBYSEDAR Audited Annual Financial StatementsSEDAR MD & A
2025-04-04 20:31U:NBYSEDAR Annual Information FormSEDAR Annual Information Form
2025-03-07 06:50U:NBYNews ReleaseNovaBay Pharmaceuticals to Hold Special Meeting of Stockholders
2025-01-23 08:00U:NBYNews ReleaseNovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal
2024-12-19 06:50U:NBYNews ReleaseNovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders
2024-12-09 06:50U:NBYNews ReleaseNovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting
2024-11-22 16:05U:NBYNews ReleaseNovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024
2024-11-15 08:00U:NBYNews ReleaseProminent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals' Proposals to Authorize the Sale of its Avenova Brand
2024-11-07 17:04U:NBYSEDAR Interim Financial StatementsSEDAR Interim MD & A
2024-11-07 16:05U:NBYNews ReleaseNovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results
2024-11-06 16:05U:NBYNews ReleaseNovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price
2024-10-29 08:00U:NBYNews ReleaseNovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLC
2024-09-20 08:30U:NBYNews ReleaseAcumen Health Holdings ("Acumen") to Acquire the Avenova brand from NovaBay Pharmaceuticals
2024-09-20 08:00U:NBYNews ReleaseNovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets
2024-08-13 17:52U:NBYSEDAR Interim MD & ASEDAR Interim Financial Statements
2024-08-13 16:05U:NBYNews ReleaseNovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results
2024-08-01 06:50U:NBYNews ReleaseNovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024
2024-07-30 06:50U:NBYNews ReleaseNovaBay Pharmaceuticals Reports Record Amazon Prime Day Sales
2024-07-29 16:05U:NBYNews ReleaseNovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering, Including Partial Exercise of Overallotment Option
2024-07-26 08:30U:NBYNews ReleaseNovaBay Pharmaceuticals Announces Pricing of $3.5 Million Underwritten Public Offering